Marketing-authorisation holder · United States
Mylan Institutional
12 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · United States
12 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
12 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| CIDOFOVIR375mg base/5ml (eq 75mg base/ml) · Solution | Cidofovir | United States | Marketed | 2012 |
| DIMETHYL SULFOXIDE50% · Solution | Dimethyl sulfoxide | United States | Not marketed | 2002 |
| DURACLON1MG/10ML (0.1MG/ML) | 5MG/10ML (0.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Clonidine | United States | Marketed | 1996 |
| ESMOLOL HYDROCHLORIDE10mg/ml | 1gm/100ml | 20mg/ml | 2gm/100ml · Injectable | Esmolol | United States | Marketed | 2004 |
| ETHACRYNATE SODIUM50mg base/vial · Injectable | Ethacrynate | United States | Marketed | 2015 |
| MESNA100mg/ml · Injectable | Mesna | United States | Marketed | 2001 |
| NALOXONE HYDROCHLORIDE0.02mg/ml | 0.4mg/ml | 1mg/ml · Injectable | Naloxone | United States | Marketed | 1986 |
| RIMSO-5050% · Solution | Dimethyl sulfoxide | United States | Marketed | 1978 |
| SOTRADECOL1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 20MG/2ML (10MG/ML) | 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 60MG/2ML (30MG/ML) · Injectable | Sodium tetradecyl sulphate | United States | Marketed | 1946 |
| SULFAMYLON5% · For solution | Mafenide | United States | Not marketed | 1998 |
| TRANEXAMIC ACID100mg/ml · Injectable | Tranexamic acid | United States | Marketed | 2011 |
| ULTIVA1mg base/vial | 2mg base/vial | 5mg base/vial · Injectable | Remifentanil | United States | Marketed | 1996 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 12 | 12 | 0 | CompaniesAll medicines |
The active substances in most of its medicines.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.